M
Mx-bio
Developed a suite of three complimentary solutions to help prevent periodontal disease
About Mx-bio
Mx-bio, a South Korean company founded in 2018, is focused on the development of treatments for periodontal disease. The company is headquartered in Seoul and operates within the drug discovery industry. Mx-bio is developing a portfolio of products to address periodontal disease, an infection affecting the tissues that support teeth. One of their key products is a biodegradable chip that is inserted between the teeth and releases medication in a controlled manner to eliminate the bacteria causing the disease. In addition to the chip, the company offers a compound antibiotic ointment and a membrane designed to promote periodontal regeneration. This suite of three complementary solutions aims to provide a comprehensive approach to preventing and treating this common oral health issue. The company has secured $3.16 million in funding from investors. Its investor base includes BiiG WAVE, A Ventures, Korea SMEs and Startups Agency, CKD Venture Capital, and HB Investment. The company has progressed through accelerator and incubator programs and has also completed an early-stage Series A funding round.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Seoul, South Korea
- Employees
- 2
- Open positions
- None listed
- Dealroom signal
- 23.0/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Jul 2025 | $10M | $41M | Undisclosed | ↗ |
| FundingOther financing | May 2021 | $0 | — | CKD Venture Capital Corporation | — |
Growth signals
Latest recorded traffic for Mx-bio is 80 monthly website visits, down 93.8% over the last three months. Mx-bio's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- SCShinhan Capital
HB Investment
KB Securities
Other known investors1 additional known investor
- CCCKD Venture Capital Corporation
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mx-bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mx-bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.